Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Welltower Inc. Common Stock (WELL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Welltower Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B), while Welltower Inc. Common Stock trades at $225.26 (market cap $159.33B). The key difference: Welltower Inc. Common Stock is far larger — about 12.7× Halozyme Therapeutics Inc. Common Stock's market cap, and Welltower Inc. Common Stock pays a 1.54% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Welltower Inc. Common Stock for 0 Days on average.
| HALO | WELL | |
|---|---|---|
Market Cap | $12.58B | $159.33B |
Volume | 2,179,278 | 2,484,986 |
Sector | Health | Real Estate |
52-Week High | $115.22 | $252.07 |
52-Week Low | $61.63 | $165.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $177.09B |
Dividend Yield | — | 1.54% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Welltower Inc. Common Stock
Welltower is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, outpatient medical facilities, and other health-related real estate.
Read more on WELL →
